Less severe retinopathy of prematurity induced by surfactant replacement therapy

Acta Paediatrica, International Journal of Paediatrics

Volumn 85, Issue 12, 1996, Pages 1491-1496

  Termote, J ^a   Schalij Delfos, N E ^b   Cats, B P ^a   Wittebol Post, D ^b   Hoogervorst, B R ^a   Brouwers, Haa ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

pulmonary surfactants; respiratory distress syndrome; retinopathy of prematurity

Indexed keywords

SURFACTANT;

ARTICLE; CONTROLLED STUDY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN; PREMATURE LABOR; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETINOPATHY; RISK FACTOR;

EID: 0029825128     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1996.tb13958.x     Document Type: Article

References (24)

1. Soll RF, Merritt TA, Hallman M. Surfactant in the prevention and treatment of respiratory distress syndrome. In: Boynton BR, Carlo WA, Jobe AH, editors. New therapies for neonatal respiratory failure. Cambridge: Cambridge University Press 1994: 49-80
2. Collaborative European Multicentre Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome; an international randomized clinical trial. Pediatrics 1988; 82: 683-91
3. Liechty EA, Donovan E, Purohit D, et al. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth neonates with respiratory distress syndrome. Pediatrics 1991; 88: 19-28
4. Long W, Thompson T, Sundell H, et al. Effects of two rescue doses of a synthetic surfactant on mortality rate and survival without bronchopulmonary dysplasia in 700-1350 g infants with respiratory distress syndrome. J Pediatr 1991; 118: 595-605
5. Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics 1992; 89: 13-20
6. Hoekstra RE, Jackson JC, Myers TF, et al. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 1991; 88: 10-8
7. Repka MX, Hudak ML, Parsa CF, Tielsch JM. Calf lung surfactant extract prophylaxis and retinopathy of prematurity. Ophthalmology 1991; 99: 531-6
8. Rankin SJA, Tubman TRJ, Halliday HL, Johnston SS. Retinopathy of prematurity in surfactant treated infants. Br J Ophthalmol 1992; 76: 202-4
9. Termote JUM, Schalij-Delfos NE, Wittebol-Post D, et al. Surfactant replacement therapy: a new factor in developing retinopathy of prematurity? Eur J Pediatr 1994; 153: 113-6
10. Holmes JM, Cronin CM, Squires P, Myers TF. Randomized clinical trial of surfactant prophylaxis in retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 1994; 31: 189-91
11. McGinnity FG, Girschek PK, Morin JD, O'Donoghue EP, Dunn MS. Bovine surfactant therapy and retinopathy of prematurity. J Pediatr Ophthalmol Strabismus 1994; 31: 238-41
12. Giedion A, Haefliger H, Dangel P. Acute pulmonary X-ray changes in hyaline membrane disease treated with artificial ventilation and positive end expiratory pressure. Pediatr Radiol 1973; 1: 145-52
13. Tan KEWP, Cats BP. Timely incidence of retinopathy of prematurity (ROP) and its consequences for the screening strategy. Am J Perinat 1989; 6: 337-40
14. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: 3 month outcome. Arch Ophthalmol 1990; 108: 195-204
15. Committee for the classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity II. The classification of retinal detachment. Arch Ophthalmol 1987; 105: 906-12
16. Hauck WW, Miike R. A proposal for examining and reporting stepwise regressions. Statistics in Medicine 1991; 10: 711-5
17. Bossi E, Koerner F. Retinopathy of prematurity. Intensive Care Med 1995; 21: 241-6
18. Van de Bor M, Ma E, Walther FJ. Cerebral blood flow velocity after surfactant instillation in preterm infants. J Pediatr 1991; 118: 285-7
19. Saliba E, Nashashibi M, Vaillant MC et al. Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates. Arch Dis Child 1994; 71: F174-8
20. Halley GC, Stenson BJ, Laing IA, McIntosh M. Acute blood pressure response to surfactant administration. Arch Dis Child 1995; 73: F197
21. Repka MX, Hardy RJ, Phelps DL, et al. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol 1993; 111: 618-20
22. Seiberth V, Freiwald R, Knorz MC. Risk factors in retinopathy of prematurity: a multivariate statistical analysis. Invest Ophthalmol Vis Sci 1991; 33: 2343-104
23. Horbar JD, Wright EC, Onstad L, et al. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics 1993; 82: 191-6
24. Casiro O, Bingham W, MacMurray B, et al. One-year follow-up of 89 infants with birthweights of 500 to 749 grams and respiratory distress syndrome randomized to two rescue doses of synthetic surfactant or air placebo. J Pediatr 1995; 126: S53-S60